scispace - formally typeset
H

Haiyan Li

Researcher at Peking University

Publications -  27
Citations -  2265

Haiyan Li is an academic researcher from Peking University. The author has contributed to research in topics: Pharmacokinetics & Medicine. The author has an hindex of 4, co-authored 19 publications receiving 1864 citations.

Papers
More filters
Journal ArticleDOI

Dose selection of chloroquine phosphate for treatment of COVID-19 based on a physiologically based pharmacokinetic model

TL;DR: A physiologically-based pharmacokinetic (PBPK) model, with parameterization of drug distribution extrapolated from animal data, was developed to predict human tissue distribution of CQ and successfully developed to optimize dosage regimens for patients with COVID-19.
Journal ArticleDOI

Cytotoxicity Evaluation of Chloroquine and Hydroxychloroquine in Multiple Cell Lines and Tissues by Dynamic Imaging System and Physiologically Based Pharmacokinetic Model

TL;DR: Both CQ and HCQ showed cytotoxicity in time-dependent manner which indicates the necessity of short period administration clinically, and also indicates relative safety of HCQ.
Posted ContentDOI

Cytotoxicity evaluation of chloroquine and hydroxychloroquine in multiple cell lines and tissues by dynamic imaging system and PBPK model

TL;DR: Both CQ and HCQ have certain cytotoxicity in time dependent manner which indicates the necessity of short period administration clinically and the relative safety of HCQ.
Journal ArticleDOI

Development of a Physiologically Based Pharmacokinetic Model for Hydroxychloroquine and Its Application in Dose Optimization in Specific COVID-19 Patients

TL;DR: Wang et al. as mentioned in this paper developed a physiologically-based pharmacokinetic (PBPK) model of hydroxychloroquine (HCQ) and integrated in vitro anti-viral effect to support dosing design of HCQ in the treatment of COVID-19 patients in China.